IL106123A0 - Benzothiazepine and benzoxazepine derivatives - Google Patents

Benzothiazepine and benzoxazepine derivatives

Info

Publication number
IL106123A0
IL106123A0 IL106123A IL10612393A IL106123A0 IL 106123 A0 IL106123 A0 IL 106123A0 IL 106123 A IL106123 A IL 106123A IL 10612393 A IL10612393 A IL 10612393A IL 106123 A0 IL106123 A0 IL 106123A0
Authority
IL
Israel
Prior art keywords
benzothiazepine
benzoxazepine derivatives
benzoxazepine
derivatives
Prior art date
Application number
IL106123A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL106123A0 publication Critical patent/IL106123A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL106123A 1992-07-01 1993-06-24 Benzothiazepine and benzoxazepine derivatives IL106123A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90741392A 1992-07-01 1992-07-01

Publications (1)

Publication Number Publication Date
IL106123A0 true IL106123A0 (en) 1993-10-20

Family

ID=25424055

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106123A IL106123A0 (en) 1992-07-01 1993-06-24 Benzothiazepine and benzoxazepine derivatives

Country Status (12)

Country Link
US (1) US5618808A (fr)
EP (1) EP0648213A1 (fr)
JP (1) JP2655754B2 (fr)
CN (1) CN1083485A (fr)
AU (1) AU4282993A (fr)
CA (1) CA2139417A1 (fr)
FI (1) FI933019A (fr)
HR (1) HRP931011A2 (fr)
HU (1) HUT68710A (fr)
IL (1) IL106123A0 (fr)
MX (1) MX9303966A (fr)
WO (1) WO1994001421A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420763D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc Acetamide derivatives
US6319915B1 (en) * 1999-08-27 2001-11-20 Pfizer Inc. Benzazepine derivatives as inhibitors of hyperproliferation diseases
KR20030082049A (ko) * 2002-04-16 2003-10-22 주식회사 효성 고투명성 폴리아미드 섬유의 제조방법
AU2006239929B2 (en) * 2005-04-22 2011-11-03 Alantos Pharmaceuticals Holding, Inc. Dipeptidyl peptidase-IV inhibitors
CN109071504B (zh) 2016-02-05 2022-03-08 戴纳立制药公司 受体相互作用蛋白激酶1的抑制剂
CN110383066B (zh) 2016-12-09 2023-03-31 戴纳立制药公司 化合物、组合物和方法
AU2023206890A1 (en) 2022-01-12 2024-08-22 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477464A (en) * 1983-02-10 1984-10-16 Ciba-Geigy Corporation Hetero-benzazepine derivatives and their pharmaceutical use
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
EP0322779A3 (fr) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Composés de benzolactame et leur utilisation pharmaceutique
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
CA2139417A1 (fr) 1994-01-20
WO1994001421A1 (fr) 1994-01-20
FI933019A0 (fi) 1993-06-30
US5618808A (en) 1997-04-08
HU9301903D0 (en) 1993-09-28
MX9303966A (es) 1994-02-28
HRP931011A2 (en) 1997-02-28
AU4282993A (en) 1994-01-31
HUT68710A (en) 1995-07-28
EP0648213A1 (fr) 1995-04-19
CN1083485A (zh) 1994-03-09
JPH07507808A (ja) 1995-08-31
FI933019A (fi) 1994-01-02
JP2655754B2 (ja) 1997-09-24

Similar Documents

Publication Publication Date Title
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
GR3023258T3 (en) 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
PL311736A1 (en) Derivatives of 1h-imidazoles
HUP9904335A3 (en) Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
GB2231329B (en) Benzazepine and benzothiazepine derivatives
ZA939291B (en) Diazepine derivatives
HU9301903D0 (en) Benzothiazepine and benzoxazepine derivatives
HU9501693D0 (en) Benzazepinone derivatives
BG97868A (en) Benzodiazepine derivatives
SG52154A1 (en) Isothiazole derivatives and their uses
ZA902150B (en) Benzazepine and benzothiazepine derivatives
GB2271564B (en) Thioalkylthio carbacephalosporin derivatives
GB2270913B (en) Chlordifluoromethoxyphenyl derivatives
GB9317692D0 (en) Benzodiazepine derivatives
PL307231A1 (en) Pyridoindolobenzodiazepines and their derivatives as antipsychotic agents
NZ248041A (en) Aminoalkyl- tetrahydrofuran derivatives and medicaments
EP0565961A3 (en) Ethyl-triazolyl derivatives
EP0486727A3 (en) Microbial reduction of benzazepine and benzothiazepine derivatives
ZA894315B (en) Benzazepine and benzothiazepine derivatives
IL115820A0 (en) Substituted tetracyclic oxazepine and thiazepine derivatives
GB9421887D0 (en) Benzodioxanylimidazoline and bensodioxanyllimidazole derivatives
IL130921A0 (en) Tetrahydroisoindole and hexahydroisoindole derivatives
IE901697L (en) Thiazepine derivatives
GB9300568D0 (en) Benzodioxanylimidazoline and benzodioxanylimidazole derivatives
GB9324403D0 (en) Benzodioxanylimidazoline and benzodioxanylimidazole derivatives